DNAlite Therapeutics fetches $1.5 mln
DNAlite Therapeutics Inc, an gastrointestinal gene therapy biotech startup, has raised $1.5 million in seed financing. Berkeley Catalyst Fund led the round with participation from University of California Berkeley, Blue Bear Ventures, SOSV, the Baldota family, BrightGene and SVE Capital.
8 August 2018•1 min read
